Answers are grounded in this paper and cite their sources.
Substituting proprietary atorvastatin for its generic formulation atorvastatin calcium does not result in a less effective management of hyperlipidemia. Our findings lend support to the approach of lowering health care costs by switching patients from branded drugs to their less expensive generic analogues.
No takes yet. Share an insight, caveat, or question.
Loch et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: